Cargando…
Treatment of nonalcoholic fatty liver disease with dapagliflozin in non-diabetic patients
Steatosis, a condition characterized by excessive lipid deposition. Although usually a benign condition, steatosis mays progress to cirrhosis or hepatocellular carcinoma. Recent evidence suggests that SGLT2 inhibitors suppress the development of nonalcoholic steatohepatitis in humans, as well as in...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7424832/ https://www.ncbi.nlm.nih.gov/pubmed/32812927 http://dx.doi.org/10.1016/j.metop.2020.100028 |